Steven Cohen’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$356K Sell
33,414
-22,993
-41% -$253K ﹤0.01% 3265
2026
Q2
$606K Buy
+56,407
New +$460K ﹤0.01% 3093
2026
Q1
– Sell
-21,298
Closed -$164K – 4009
2025
Q4
$164K Buy
+21,298
New +$175K ﹤0.01% 3678
2023
Q2
– Sell
-3,100
Closed -$25.8K – 2366
2023
Q1
$25.8K Buy
+3,100
New +$28.8K ﹤0.01% 1934

Other funds holding FENC

Steven Cohen's FENC Position: Q3 2026 in Review

Steven Cohen reduced its Fennec Pharmaceuticals (FENC) stake by 41% in Q3 2026, selling an estimated $253K and leaving 33,414 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #3265.

Steven Cohen first reported a position in FENC in Q1 2023 and has held it in 4 quarters since. The position peaked at $606K in Q2 2026. 119 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

  • Steven Cohen held 33,414 shares of Fennec Pharmaceuticals worth $356K as of Q3 2026.
  • Steven Cohen sold 22,993 Fennec Pharmaceuticals shares in Q3 2026, an estimated $253K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3265 holding.
  • Steven Cohen first reported a position in Fennec Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
  • Steven Cohen's Fennec Pharmaceuticals position peaked at $606K in Q2 2026.
  • 119 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.